Clinical and Translational Science Pilot Program (CTSP)

The Clinical Translational Science Pilot Program (CTSP) is now accepting applications for the 2025 CTSI Translational Science Pilot Award, funded through the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Awards (CTSA) Program. The goal of the CTSI Translational Science Pilot Award is to fund highly meritorious research for the development of preliminary data to enable researchers to be competitive in applying for extramural funding that advances clinical and translational science.

This request for applications (RFA) is designed to stimulate and support transformative, innovative, interdisciplinary studies that seek to advance team science, implementation science, inter-institutional partnerships and/or community partnerships through understanding and addressing  the biological, behavioral, environmental, sociocultural and structural factors that influence women’s health across the lifespan. 

Successful translational science studies focus on a specific clinical and translational research area aimed to develop or test a translational science-directed hypothesis that addresses a barrier to progression of turning observations in the laboratory, clinic and community into interventions that improve the health of people more quickly. 

By applying one or more translational science principals, a translational science-directed hypothesis should generate a scientific, operational, financial or administrative innovation that addresses longstanding challenges along the translational research pipeline, transforming the way that research is done, making it faster, more efficient and more impactful.  

Upcoming Information and Ideation Sessions

Two information and ideation sessions will be held. Each session will include a short 30-minute presentation on Translational Science and question and answer followed by a one hour and 30-minute ideation workshop. 

1. Information and Ideation Session 1 (VIRTUAL): Monday, August 26, 2024, 2-3:30 p.m.
2. Information and Ideation Session 2 (VIRTUAL): Friday, September 6, 2024, 9:30– 11 a.m.

Prospective applicants are encouraged to attend for the virtual ideation workshop. This workshop is designed to elevate the strength and quality of proposals through early peer review and panel feedback. This workshop is a fantastic opportunity for applicants to present their initial ideas in a professional and friendly forum. Research shows that ideas that have gone through several iteration processes are stronger and have better potential of securing funding.

• If you plan to present your ideas, please choose the "presenter" option in the registration link and prepare a 5-slide, 5-minute presentation that includes the following information:
  • Translational science research question(s) of your project
  • Overview of the research strategy
  • Significance to the field of translational science 
  • How you are working as a team to do your proposed research
  • How the research question addresses a critical scientific gap or unmet need in women’s health
• Workshop audience will include a specially selected mock review panel, as well as general members of The Ohio State University and Nationwide Children’s Hospital community. All audience participants will have the opportunity to ask probing questions and offer comments on your ideas. You will also receive expert comments from the review panel.

We will accommodate up to eight presentations in the workshop, on a first come, first served basis. Participation in this ideation workshop is not prerequisite for application to the RFA, and feedback in this workshop is not indicative of application success.